Peptide molecular weight, printed on every certificate of analysis in daltons (Da) or kilodaltons (kDa), is one of the least understood numbers on the page. It tells a researcher whether a vial contains the right compound, how that compound will behave in solution, and how quickly it clears from a biological system once injected. Most reconstitution errors and concentration miscalculations trace back to someone skimming past this figure rather than using it.
What peptide molecular weight actually measures
A dalton is a unit of mass equal to roughly one twelfth the mass of a carbon-12 atom, close enough to the mass of a single hydrogen atom to use as an intuitive reference point. Peptides fall in the 2 to 50 amino acid range by the standard biochemical definition; StatPearls classifies chains of 10 to 20 residues as oligopeptides and anything longer as a polypeptide (Kaprive and Krishnamurthy, StatPearls 2023). Most research peptides sold as reference material, BPC-157, TB-500, the GHRP family, sit well under 5,000 Da. Full proteins and antibodies run into the tens of kilodaltons, which is why the unit switches once a chain crosses roughly 10,000 Da.
Molecular weight is not a measure of purity. A vial can report a perfect theoretical molecular weight and still contain a mixture of the target peptide, truncated synthesis byproducts, and residual solvent. Purity comes from a separate HPLC percentage, covered in our certificate of analysis guide. Molecular weight and purity answer different questions, and a COA that only reports one of them is incomplete.
Calculating it from the sequence
Each amino acid residue has a fixed average mass once it is bonded into a chain, glycine contributes 57.05 Da, alanine 71.08 Da, tryptophan 186.21 Da, and so on. Peptide bond formation releases one water molecule per bond, so the chain's total mass is the sum of the residue masses plus a single water molecule (18.02 Da) added back to account for the free amino and carboxyl termini. A 15-residue peptide like BPC-157 sums to a molecular formula of C62H98N16O22 and a calculated mass of 1,419.5 Da, a figure confirmed independently by PubChem (PubChem CID 9941957).
Mass spectrometry labs distinguish two versions of this number. Monoisotopic mass uses the exact mass of each element's most common isotope (carbon-12, hydrogen-1, nitrogen-14) and is what an LC-MS instrument reports as its sharpest peak. Average mass uses the natural isotopic abundance across all isotopes of each element and is what most vendor COAs list as the standard molecular weight.
Below roughly 1,500 Da the two values sit close enough together that the distinction rarely matters for a research buyer. Above that threshold, larger peptides carry enough heavy-isotope atoms that the two figures can diverge by a few daltons, a gap that matters to an analytical chemist matching a mass spec peak list against a database entry (StatPearls, mass spectrometry peak matching).
Reading molecular weight on a certificate of analysis
A COA typically lists a theoretical molecular weight, calculated directly from the amino acid sequence, next to an observed molecular weight, measured by mass spectrometry on the actual batch. The two should match within a fraction of a dalton to a couple of daltons, depending on the instrument's resolution. A larger gap is a warning sign.
An observed mass roughly 16 Da higher than theoretical usually points to oxidation of a methionine or cysteine residue, a failure mode covered in our oxidation prevention guide. A gap in the hundreds of daltons suggests a truncated sequence, a missed coupling step during synthesis, or the wrong compound in the vial entirely.
Some COAs report two different molecular weights for the same compound: one for the free peptide and one for the acetate salt form the peptide typically ships as. The acetate counterions add mass without adding active compound, so a vial labeled by the salt-form molecular weight contains slightly less peptide by mass than the number on the label implies. This matters directly for concentration math on the dosing calculator, since converting a vial's stated milligrams into a millimolar research concentration only works correctly when the researcher knows which molecular weight the label is using.
Why molecular weight shapes pharmacokinetics
Molecular weight is one of the strongest predictors of how quickly a peptide clears the body through renal filtration. A 2012 analysis in British Journal of Clinical Pharmacology (Czock, Keller, and Seidling, n=21 peptide and protein drugs) modeled pharmacokinetic data across 21 approved peptide and protein drugs in patients with severe renal impairment. The paper found a continuous, non-linear relationship between molecular weight and pharmacokinetic change under renal impairment, with low molecular weight peptides showing an average 30 percent reduction in clearance and a 3.1-fold prolongation in half-life once kidney function was severely reduced. Small peptides pass through glomerular filtration easily; increasing size is one of the standard ways to slow that process down.
The GLP-1 receptor agonist class is the clearest illustration of this principle at work in a marketed drug. Native GLP-1 has a plasma half-life measured in minutes. Semaglutide, by contrast, carries a C18 fatty diacid chain attached through a linker at a single lysine residue, raising its molecular weight to roughly 4,114 Da (PubChem CID 56843331) and giving it a hydrodynamic profile close to serum albumin.
The design paper behind the compound describes how that fatty acid modification drives high-affinity albumin binding, which shields the peptide from renal filtration and extends its plasma residence time (Lau et al., Journal of Medicinal Chemistry, 2015). Our half-life and pharmacokinetics guide covers this mechanism, and the retatrutide research literature, in more depth.
Molecular weight across common research peptides
Compounds discussed on our compound reference pages span a wide molecular weight range even though most are described loosely as "peptides."
- BPC-157, 15 residues, 1,419.5 Da (PubChem CID 9941957)
- CJC-1295 with DAC, 29 residues plus the drug affinity complex, 3,647.2 Da (PubChem CID 91971820)
- Thymosin Beta-4 (TB-500), 43 residues, 4,963.4 Da (PubChem CID 45382195)
- Semaglutide, 31 residues plus a C18 fatty diacid, roughly 4,114 Da (PubChem CID 56843331)
- Retatrutide, 39 residues plus a fatty acid conjugate, roughly 4,731 Da per manufacturer chemical databases
The pattern is not subtle. Compounds engineered for extended half-life, semaglutide, retatrutide, tirzepatide, cluster near 4,100 to 4,900 Da specifically because their designers added mass on purpose. Short repair and signaling peptides like BPC-157 stay under 1,500 Da because nothing in their mechanism benefits from a longer circulating half-life.
Mistakes to avoid when reading the number
Two molecular weights on the same COA, free peptide and acetate salt, is the single most common source of confusion, and it changes the actual milligram content of the compound in the vial. Assuming molecular weight predicts solubility is another one; a peptide's charge distribution and hydrophobic residue pattern determine solubility far more than its overall mass, a point covered in our solubility guide. Finally, molecular weight does not tell a researcher anything about sterility or filter compatibility. A 0.22 micron syringe filter, standard for reconstituting research peptides under aseptic technique, has pores tens of thousands of times larger than any peptide in this weight range and works identically whether the peptide is 1,400 Da or 5,000 Da.